statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Titoli in rialzo
Il titolo Evoke Pharma (NASDAQ:EVOK) ha osservato un incremento del 41,47% a 0,75 dollari durante la sessione pre-market di mercoled .
Le azioni di Jaguar Health (NASDAQ:JAGX) sono...

12 titoli sanitari in movimento, pre-market del 10/04/2024

Acciones al alza
Jaguar Health (NASDAQ:JAGX) avanzaron un 43,99% para establecerse en los 0,13 d lares durante la sesi n del pre-market del mi rcoles.
Adial Pharmaceuticals (NASDAQ:ADIL) ganaron un...

12 acciones de salud en movimiento durante la preapertura del 10/04/2024

Jaguar Health reported all proposals were approved by stockholders, and the company will not be implementing a reverse split at this time.
read more...

Why Jaguar Health Stock Is Soaring After-Hours

Dr. Massimo Radaelli's core focus will be on further expanding Jaguar's commercial footprint outside the U.S.Dr. Radaelli was instrumental in facilitating the recent out-license agreement with GEN...

Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International

Q4 2023 Jaguar Health Inc Earnings Call Transcript

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Jaguar Health reports 2023 EPS ($1.79) vs. ($36.18) last year

Net revenue was approximately $9.8 million for the year ended December 31, 2023 versus approximately $12.0 million for the year ended December 31, 2022, a decrease of 18%Net Q4 2023 revenue of...

Jaguar Health Reports 2023 Financial Results

Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript...

Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript

Jaguar Health, Inc. ( NASDAQ:JAGX ) shareholders are no doubt pleased to see that the share price has bounced 55% in...

Jaguar Health, Inc. (NASDAQ:JAGX) Shares Fly 55% But Investors Aren't Buying For Growth

Click here to register for April 1 investor webcastCompany plans to file its Earnings Report on April 1, 2024 on Form 10-K for the year ended December 31, 2023SAN FRANCISCO, CA / ACCESSWIRE / March...

Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Volume	9.74M
52-Wk High	$1.22
52-Wk Low	$0.0512

Period	Estimated	Reported	Surprise	Result
Q4'23	--	$1.40	--	N/A
Q3'23	-$1.23	-$0.38	69.11%	BEAT
Q2'23	-$1.53	-$0.42	72.55%	BEAT
Q1'23	--	-$2.39	--	N/A
Q4'22	-$9.75	$11.82	221.23%	BEAT

JAGX Jaguar Health Inc

About

Feed

News

Earnings

Fundamentals